Macrogenics (MGNX) Profit After Tax (2012 - 2026)
Macrogenics' (MGNX) quarterly Profit After Tax came in at -$36.8 million in Q1 2026, up 10.39% year-on-year from -$33.3 million in Q1 2025, and down 159.78% on a QoQ basis from -$14.2 million in Q4 2025.
Macrogenics (MGNX) Profit After Tax (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Profit After Tax data on file, last reported at -$36.8 million in Q1 2026.
- On a quarterly basis, Profit After Tax rose 10.39% year-over-year to -$36.8 million in Q1 2026; TTM through Mar 2026 was -$70.4 million, a 26.09% decrease from a year earlier, with the FY2025 full-year figure at -$74.6 million, down 11.45% from the prior year.
- Profit After Tax for Q1 2026 stood at -$36.8 million, down from -$14.2 million in the prior quarter.
- Over the last five years, Profit After Tax for MGNX reached as high as $57.5 million in Q2 2023 and fell as low as -$66.4 million in Q1 2022.
- Historically, Profit After Tax has averaged -$18.1 million across 5 years, with a median of -$36.3 million in 2025.
- On a YoY basis, Profit After Tax climbed as much as 239.14% in 2023 and fell as far as 459.65% in 2023.
- Year by year, Profit After Tax stood at $12.8 million in 2022, then tumbled by 459.65% to -$46.0 million in 2023, then soared by 66.53% to -$15.4 million in 2024, then climbed by 8.14% to -$14.2 million in 2025, then tumbled by 159.78% to -$36.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$36.8 million in Q1 2026, -$14.2 million in Q4 2025, and $16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -36.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.77 Mn |
| Dec 31, 2025 | -14.16 Mn |
| Sep 30, 2025 | 16.82 Mn |
| Jun 30, 2025 | -36.25 Mn |
| Mar 31, 2025 | -41.04 Mn |
| Dec 31, 2024 | -15.41 Mn |
| Sep 30, 2024 | 56.31 Mn |
| Jun 30, 2024 | -55.66 Mn |
| Mar 31, 2024 | -52.19 Mn |
| Dec 31, 2023 | -46.04 Mn |
| Sep 30, 2023 | 17.59 Mn |
| Jun 30, 2023 | 57.47 Mn |
| Mar 31, 2023 | -38.01 Mn |
| Dec 31, 2022 | 12.80 Mn |
| Sep 30, 2022 | -24.60 Mn |
| Jun 30, 2022 | -41.30 Mn |
| Mar 31, 2022 | -66.44 Mn |
| Dec 31, 2021 | -58.08 Mn |
| Sep 30, 2021 | -52.89 Mn |
| Jun 30, 2021 | -39.94 Mn |